Lv62
2370 积分 2024-06-26 加入
Lung cancer
2个月前
已完结
Small-cell lung cancer
2个月前
已完结
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
3个月前
已完结
[Response characteristics of tislelizumab combined with chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer]
3个月前
已完结
The rebirth of epitope-based patent claims
4个月前
已完结
Determinants of successful minimally invasive surgery (MIS) for resectable non-small cell lung cancer (NSCLC) after neoadjuvant therapy
4个月前
已完结
Targeting neoantigens to augment antitumour immunity
4个月前
已完结
Targeting neoantigens to augment antitumour immunity
4个月前
已完结
Non-small-cell lung cancer
4个月前
已完结
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
